Receiving an Honorary FGIN, Dr Alper is recognised for his ongoing commitment to the field of guideline science.
Dr. Alper is board certified in family medicine and clinical informatics. He graduated from Hahnemann University (now Drexel University School of Medicine), completed a fellowship at University of Missouri-Columbia, and continued as Clinical Research Assistant Professor serving roles in research, clinical practice and education at University of Missouri-Columbia School of Medicine for five years.
In 1995, Dr. Alper founded DynaMed, an evidence-based clinical reference, with the mission to provide the most useful information to health care professionals at the point-of-care. Dr. Alper established systematic literature surveillance as a method to extend evidence-based medicine principles and sustain continuous updating of DynaMed.
Dr. Alper’s mission expanded to provide the most useful support for healthcare decision making. He has become a frequent presenter and opinion leader across many related communities including American Medical Informatics Association, Association of Medical Directors of Information Systems, Guidelines International Network, Health Level Seven International, International Shared Decision Making Society, and Mobilizing Computable Biomedical Knowledge.
Dr. Alper has advanced the methodology of evidence-based medicine through systems to support rapid development of high-quality guidelines with limited resources, modernized models for how to organize evidence and guidance for searches for clinical use, and defined certainty of net benefit as a focal point for what matters in healthcare decision making. In 2019, Dr. Alper developed a novel method to cope with the current challenge of inconsistency across clinical practice guidelines.
In 2018, Dr. Alper started scalable efforts to define the standard for computable expression of evidence and statistics with a project to extend Fast Healthcare Interoperability Resources for Evidence-Based Medicine knowledge assets (EBMonFHIR). In 2020, to scale these efforts for immediate needs, Dr. Alper started the COVID-19 Knowledge Accelerator, changed his mission to enable standard-based machine-interpretable expression of knowledge, especially related to healthcare and scientific evidence, and founded Computable Publishing LLC to fulfill this mission. In 2021, Dr. Alper created the Fast Evidence Interoperability (FEvIR) Platform and founded the Scientific Knowledge Accelerator Foundation as a nonprofit organization with a board of directors from 6 countries.